• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人类免疫缺陷病毒I型逆转录酶的非核苷类逆转录酶抑制剂结合口袋内Tyr-318的突变分析。

Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase.

作者信息

Pelemans H, Esnouf R M, Jonckheere H, De Clercq E, Balzarini J

机构信息

Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium.

出版信息

J Biol Chem. 1998 Dec 18;273(51):34234-9. doi: 10.1074/jbc.273.51.34234.

DOI:10.1074/jbc.273.51.34234
PMID:9852086
Abstract

The highly conserved Tyr-318 is part of the non-nucleoside reverse transcriptase inhibitor (NNRTI)-specific lipophilic pocket of human immunodeficiency virus type I reverse transcriptase (RT) and makes contact within 4 A with the NNRTIs in all reported RT/NNRTI complexes. Using site-directed mutagenesis, six mutant RTs were constructed bearing the mutations Y318H, Y318K, Y318L, Y318C, Y318W, and Y318F. We found that only the Y318W and Y318F mutant RTs retained substantial RT activity, whereas the catalytic activities of the Y318K, Y318C, Y318H, and Y318L RT mutants were less than 5% of the wild-type activity. The Y318F mutant RT retained substantial sensitivity to the majority of NNRTIs tested, whereas the Y318W mutant RT showed varying degrees of resistance to NNRTIs. Subunit-specific site-directed mutagenesis revealed that there was no difference in the catalytic activity or resistance/sensitivity spectrum toward NNRTIs regardless of whether the Tyr-318 mutation was introduced in both subunits or only in the p66 subunit of RT. Recombinant viruses harboring the Y318F or Y318W mutation in the RT showed a similar resistance/sensitivity pattern to NNRTIs as their corresponding 318 mutant recombinant RTs. Our findings stress a functional or structural role for Tyr-318 in wild-type RT and argue for the design of novel NNRTIs that interact more closely with this amino acid in the NNRTI-specific pocket of human immunodeficiency virus type I RT.

摘要

高度保守的酪氨酸-318是I型人类免疫缺陷病毒逆转录酶(RT)非核苷类逆转录酶抑制剂(NNRTI)特异性亲脂口袋的一部分,在所有已报道的RT/NNRTI复合物中,它与NNRTI在4埃范围内相互作用。通过定点诱变,构建了六个携带Y318H、Y318K、Y318L、Y318C、Y318W和Y318F突变的突变型RT。我们发现,只有Y318W和Y318F突变型RT保留了大量的RT活性,而Y318K、Y318C、Y318H和Y318L RT突变体的催化活性不到野生型活性的5%。Y318F突变型RT对大多数测试的NNRTI仍保持高度敏感性,而Y318W突变型RT对NNRTI表现出不同程度的抗性。亚基特异性定点诱变表明,无论酪氨酸-318突变是在两个亚基中引入还是仅在RT的p66亚基中引入,其对NNRTI的催化活性或抗性/敏感性谱均无差异。在RT中携带Y318F或Y318W突变的重组病毒对NNRTI的抗性/敏感性模式与其相应的318突变重组RT相似。我们的研究结果强调了酪氨酸-318在野生型RT中的功能或结构作用,并支持设计与I型人类免疫缺陷病毒RT的NNRTI特异性口袋中的该氨基酸更紧密相互作用的新型NNRTI。

相似文献

1
Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptase.对人类免疫缺陷病毒I型逆转录酶的非核苷类逆转录酶抑制剂结合口袋内Tyr-318的突变分析。
J Biol Chem. 1998 Dec 18;273(51):34234-9. doi: 10.1074/jbc.273.51.34234.
2
The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance.HIV-1逆转录酶的赖氨酸103天冬酰胺突变:一种新的耐药机制。
J Mol Biol. 2001 Jun 1;309(2):437-45. doi: 10.1006/jmbi.2001.4648.
3
Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138.对人类免疫缺陷病毒1型逆转录酶第138位氨基酸进行定点诱变。
Virology. 2001 Feb 1;280(1):97-106. doi: 10.1006/viro.2000.0742.
4
HIV-1 reverse transcriptase connection subdomain mutations involved in resistance to approved non-nucleoside inhibitors.HIV-1 逆转录酶连接亚结构域突变与对已批准的非核苷抑制剂的耐药性有关。
Antiviral Res. 2011 Nov;92(2):139-49. doi: 10.1016/j.antiviral.2011.08.020. Epub 2011 Aug 28.
5
Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant.与野生型HIV-1逆转录酶复合的8-氯和9-氯替博韦的晶体结构以及与Tyr181Cys HIV-1逆转录酶耐药突变体复合的8-氯替博韦的晶体结构。
J Mol Biol. 1996 Dec 20;264(5):1085-100. doi: 10.1006/jmbi.1996.0698.
6
Chimeric human immunodeficiency virus type 1 and feline immunodeficiency virus reverse transcriptases: role of the subunits in resistance/sensitivity to non-nucleoside reverse transcriptase inhibitors.嵌合型1型人类免疫缺陷病毒和猫免疫缺陷病毒逆转录酶:亚基在对非核苷类逆转录酶抑制剂的耐药性/敏感性中的作用
Mol Pharmacol. 2002 Feb;61(2):400-6. doi: 10.1124/mol.61.2.400.
7
Impact of residues in the nonnucleoside reverse transcriptase inhibitor binding pocket on HIV-1 reverse transcriptase heterodimer stability.非核苷类逆转录酶抑制剂结合口袋中的残基对HIV-1逆转录酶异二聚体稳定性的影响。
Curr HIV Res. 2008 Mar;6(2):130-7. doi: 10.2174/157016208783885065.
8
Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097.临床上相关的赖氨酸103天冬酰胺/酪氨酸181半胱氨酸双突变HIV-1逆转录酶与ATP和非核苷抑制剂HBY 097复合物的晶体结构。
J Mol Biol. 2007 Jan 5;365(1):77-89. doi: 10.1016/j.jmb.2006.08.097. Epub 2006 Sep 15.
9
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.1型人类免疫缺陷病毒逆转录酶3'区域的一种突变(Y318F),与非核苷类逆转录酶抑制剂耐药性相关。
J Virol. 2002 Jul;76(13):6836-40. doi: 10.1128/jvi.76.13.6836-6840.2002.
10
The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.人类免疫缺陷病毒1型(HIV-1)逆转录酶p51亚基中的N137和P140氨基酸以及p66亚基中的P95氨基酸对于维持催化活性和设计新型抗HIV-1药物至关重要。
FEBS Lett. 2005 Apr 25;579(11):2294-300. doi: 10.1016/j.febslet.2005.02.077.

引用本文的文献

1
Fitness Cost of Antiretroviral Drug Resistance Mutations on the Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure.在经历病毒学失败的个体进行分析性抗逆转录病毒治疗中断期间,抗逆转录病毒药物耐药性突变对该基因的适应性代价
Pathogens. 2021 Nov 3;10(11):1425. doi: 10.3390/pathogens10111425.
2
A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity.人类免疫缺陷病毒1型逆转录酶连接子结构域中第400位的多态性会影响对非核苷类逆转录酶抑制剂的敏感性以及核糖核酸酶H活性。
PLoS One. 2013 Oct 2;8(10):e74078. doi: 10.1371/journal.pone.0074078. eCollection 2013.
3
The "Connection" Between HIV Drug Resistance and RNase H.
HIV耐药性与核糖核酸酶H之间的“关联”
Viruses. 2010 Jul 1;2(7):1476-1503. doi: 10.3390/v2071476.
4
Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors.1型人类免疫缺陷病毒逆转录酶连接亚结构域中的氨基酸突变N348I赋予对核苷类和非核苷类逆转录酶抑制剂的多类耐药性。
J Virol. 2008 Apr;82(7):3261-70. doi: 10.1128/JVI.01154-07. Epub 2008 Jan 23.
5
Human immunodeficiency virus mutagenesis during antiviral therapy: impact of drug-resistant reverse transcriptase and nucleoside and nonnucleoside reverse transcriptase inhibitors on human immunodeficiency virus type 1 mutation frequencies.抗病毒治疗期间的人类免疫缺陷病毒诱变:耐药性逆转录酶以及核苷类和非核苷类逆转录酶抑制剂对1型人类免疫缺陷病毒突变频率的影响。
J Virol. 2005 Sep;79(18):12045-57. doi: 10.1128/JVI.79.18.12045-12057.2005.
6
High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations.尽管不断出现突变,但在药物压力下,人类免疫缺陷病毒1型逆转录酶仍具有高度的序列保守性。
J Virol. 2005 Aug;79(16):10718-29. doi: 10.1128/JVI.79.16.10718-10729.2005.
7
The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.苯甲基噻唑基硫脲非核苷逆转录酶(RT)抑制剂MSK-076会导致2型人类免疫缺陷病毒RT活性位点出现耐药性突变。
J Virol. 2004 Jul;78(14):7427-37. doi: 10.1128/JVI.78.14.7427-7437.2004.
8
A mutation in the 3' region of the human immunodeficiency virus type 1 reverse transcriptase (Y318F) associated with nonnucleoside reverse transcriptase inhibitor resistance.1型人类免疫缺陷病毒逆转录酶3'区域的一种突变(Y318F),与非核苷类逆转录酶抑制剂耐药性相关。
J Virol. 2002 Jul;76(13):6836-40. doi: 10.1128/jvi.76.13.6836-6840.2002.